Elegant way of pinpointing how new drugs exert beneficial effects

A collaborative effort by cancer researchers and chemists has resulted in the identification of a new drug target in leukemia and creation of a candidate drug that hits the target. More important, the research demonstrates a new, highly accurate way of proving how this and certain other classes of drugs work — extremely valuable information in the risky business of drug development. (Mehr in: Cancer News — ScienceDaily)